Prognostic factors in controlled ovarian hyperstimulation

Fertility and Sterility

Volumn 72, Issue 5, 1999, Pages 932-936

  Tinkanen, Helena ^a   Bläuer, Merja ^a   Laippala, Pekka ^a   Tuohimaa, Pentti ^a   Kujansuu, Erkki ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

FSH; Inhibin B; IVF; Ovarian response prediction; Vascular resistance

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GONADORELIN DERIVATIVE; GONADOTROPIN; INHIBIN;

AGE; ARTERY RESISTANCE; ARTICLE; BODY MASS; FEMALE; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; OVARY FOLLICLE; OVARY HYPERSTIMULATION; PARITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIOIMMUNOASSAY; TRANSVAGINAL ECHOGRAPHY;

ADULT; FEMALE; FERTILIZATION IN VITRO; HUMANS; LOGISTIC MODELS; OVULATION INDUCTION; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; STIMULATION, CHEMICAL;

EID: 0344994652     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(99)00397-0     Document Type: Article

References (18)

1. Buyalos R.P., Daneshmand S., Brzechffa P.R. Basal estradiol and follicle-stimulating hormone predict fecundity in women of advanced reproductive age undergoing ovulation induction therapy. Fertil Steril. 68:1997;272-277.
2. Evers J.L.H., Slaats P., Land J.A., Dumoulin J.C.M., Dunselman G.A.J. Elevated levels of basal estradiol 17β predict poor response in patients with normal basal levels of follicle stimulating hormone undergoing in vitro fertilization. Fertil Steril. 69:1998;1010-1014.
3. Seifer D.B., Lambert-Messerlian G., Hogan J., Gardiner A.C., Blazar A.S., Berk C.A. Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertil Steril. 67:1997;110-114.
4. Tomas C., Nuojua-Huttunen S., Martikainen H. Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro-fertilization. Hum Reprod. 12:1997;220-223.
5. Engmann L, Sladkevicius P, Agrawal R, Bekir J, Campbell S, Tan SL. The value of ovarian stromal blood flow velocity measurement after pituitary suppression in the prediction of ovarian responsiveness and outcome of IVF treatment [abstract no. 282]. In: Program and abstracts of the 16th World Congress on Fertility and Sterility and 54th Annual Meeting of the American Society for Reproductive Medicine, New York; Elsevier Science Inc. 1998:105-6.
6. Bloechle M., Schreiner T.H., Kuchler I., Schurenkämper P., Lisse K. Colour Doppler assessment of ascendent uterine artery perfusion in an in-vitro fertilization-embryo transfer program after pituitary desensitization and ovarian stimulation with human recombinant follicle stimulating hormone. Hum Reprod. 12:1997;1772-1777.
7. Zullo F., DiCarlo C., Pellicano M., Catizone C., Martrantonio P., Nappi C. Superovulation with urinary follicle-stimulating hormone correlations with body mass index and body fat distribution . Gynecol Endocrinol. 10:1996;17-21.
8. Merz E., Miric-Tesanic D., Bahlmann F., Weber G., Wellek S. Sonographic size of the uterus and ovaries in pre- and postmenopausal women. Ultrasound Obstet Gynecol. 7:1996;38-42.
9. Sladkevicius P., Valentin L., Marsal K. Blood flow velocity in the uterine and ovarian arteries during menstruation. Ultrasound Obstet Gynecol. 4:1994;421-427.
10. Scott R.T., Hofmann G.E. Prognostic assessment of ovarian reserve. Fertil Steril. 63:1995;1-11.
11. Schipper I., Jong F.H., Fauser B.C.J.M. Lack of correlation between maximum early follicular phase serum follicle stimulating hormone concentrations and menstrual cycle characteristics in women under the age of 35 years. Hum Reprod. 13:1998;1442-1448.
12. Danforth D.R., Arbogast L.K., Mroueh J., Kim M.H., Kennard E.A., Seifer D.B., et al. Dimeric inhibin. A direct marker of ovarian aging. Fertil Steril. 70:1998;119-123.
13. Taymor M.L. The regulation of follicle growth some clinical implications in reproductive endocrinology . Fertil Steril. 65:1996;235-247.
14. Suzuki F., Sasano H., Takaya R., Fukaya T., Yajima A., Nagura H. Cyclic changes of vasculature and vascular phenotypes in normal human ovaries. Hum Reprod. 13:1998;953-959.
15. Van Blerkom J., Antczak M., Schrader R. The development potential of the human oocyte is related to the dissolved oxygen content of follicular fluid association with vascular endothelial growth factor levels and perifollicular blood flow characteristics . Hum Reprod. 12:1997;1047-1055.
16. Aleem F.A., Predanic M. Transvaginal color Doppler determination of the ovarian and uterine flow characteristics in polycystic ovary disease. Fertil Steril. 65:1996;510-516.
17. Agrawal R., Sladkevicius P., Engmann L., Conway G.S., Payne N.N., Bekis J., et al. Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries. Hum Reprod. 13:1998;651-655.
18. Moohan J.M., Curcio K., Leoni M., Healy D., Hurley V. Low intraovarian vascular resistance a marker for severe ovarian hyperstimulation syndrome . Fertil Steril. 67:1997;728-732.